Real-Life Experience of Continuously Infused Ceftolozane/Tazobactam in Patients with Bronchiectasis and Multidrug-Resistant Pseudomonas aeruginosa Infection in the Outpatient Setting

(1) Background: Ceftolozane/tazobactam (C/T) is a novel β-lactam/β-lactamase inhibitor with excellent activity against the multidrug-resistant (MDR) P. aeruginosa. Continuous infusion (CI) dosing allows the optimization of pharmacokinetic and pharmacodynamic (PK/PD) properties of β-lactam antibiotic...

Descripción completa

Detalles Bibliográficos
Autores principales: Venuti, Francesco, Gaviraghi, Alberto, De Nicolò, Amedeo, Stroffolini, Giacomo, Longo, Bianca Maria, Di Vincenzo, Alessia, Ranzani, Fabio Antonino, Quaranta, Matilde, Romano, Francesca, Catellani, Eleonora, Marchiaro, Carlotta, Cinnirella, Giacoma, D’Avolio, Antonio, Bonora, Stefano, Calcagno, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376517/
https://www.ncbi.nlm.nih.gov/pubmed/37508309
http://dx.doi.org/10.3390/antibiotics12071214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376517/
https://www.ncbi.nlm.nih.gov/pubmed/37508309
http://dx.doi.org/10.3390/antibiotics12071214

Ejemplares similares